Multicenter evaluation of M2BPGi as a biomarker for liver fibrosis and hepatocellular carcinoma in chronic hepatitis B and C patients in Malaysia. // Advances in Biomarker Sciences and Technology. – URL: https://www.sciencedirect.com/science/article/pii/S2543106426000116?dgcid=rss_sd_all
Multicenter evaluation of M2BPGi as a biomarker for liver fibrosis and hepatocellular carcinoma in chronic hepatitis B and C patients in Malaysia. Advances in Biomarker Sciences and Technology. https://www.sciencedirect.com/science/article/pii/S2543106426000116?dgcid=rss_sd_all
“Multicenter evaluation of M2BPGi as a biomarker for liver fibrosis and hepatocellular carcinoma in chronic hepatitis B and C patients in Malaysia.” Advances in Biomarker Sciences and Technology.
@article{article33270,
title = {Multicenter evaluation of M2BPGi as a biomarker for liver fibrosis and hepatocellular carcinoma in chronic hepatitis B and C patients in Malaysia},
journal = {Advances in Biomarker Sciences and Technology},
url = {https://www.sciencedirect.com/science/article/pii/S2543106426000116?dgcid=rss_sd_all}
}
ABSTRACT Three‐dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often...
ABSTRACT Cancer complexity arises not only from host genetics but also from interactions between the host and microbial communities. However, the field remains fragmented, and a systems‐level framework is needed to guide precision...
ABSTRACT The genomic features associated with the histopathological spectrum from precursor glandular lesions to invasive lung adenocarcinoma remain incompletely characterized. In this retrospective cross‐sectional study, we performed...
ABSTRACT This study analyzed self‐reported pain‐related outcomes of 40,785 surgical patients from 125 centers collected by CAPOPS (China Acute Postoperative Pain Study) between September 2019 and August 2023, to characterize the current...